A REGISTRY OF PATIENTS TREATED WITH DROTRECOGIN ALFA (ACTIVATED) IN BELGIAN INTENSIVE CARE UNITS - AN OBSERVATIONAL STUDY

Jean Louis Vincent; P F Laterre; Johan Decruyenaere; Herbert Spapen; Jan Raemaekers; Felipe Damas; Peter Rogiers; Magali Sartral; T. Haentjens; David R. Nelson; Jonathan Janes

doi:10.1179/acb.2008.004

Back

A REGISTRY OF PATIENTS TREATED WITH DROTRECOGIN ALFA (ACTIVATED) IN BELGIAN INTENSIVE CARE UNITS - AN OBSERVATIONAL STUDY

Article 2008 en

Abstract

1 min read

Comparing Belgian reimbursement registry data with those of a voluntary severe sepsis register provides support for the observation that DrotAA reduces mortality rates in severe sepsis and septic shock.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2006

Use of an integrated clinical trial database to evaluate the effect of timing of drotrecogin alfa (activated) treatment in severe sepsis

Jean Louis Vincent, James M. O’Brien, Arthur P. Wheeler, Xavier Wittebole, Rekha Garg, Benjamin Trzaskoma, David P. Sundin

Article2007

EARLY- VERSUS LATE-ONSET SHOCK IN EUROPEAN INTENSIVE CARE UNITS

Yasser Sakr, Jean Louis Vincent, Tobias Schuerholz, Daniela Filipescu, Alain Romain, Hans Hjelmqvist, Konrad Reinhart

A REGISTRY OF PATIENTS TREATED WITH DROTRECOGIN ALFA (ACTIVATED) IN BELGIAN INTENSIVE CARE UNITS - AN OBSERVATIONAL STUDY

Abstract

Discussion(0)

Related publications

Use of an integrated clinical trial database to evaluate the effect of timing of drotrecogin alfa (activated) treatment in severe sepsis

Drotrecogin Alfa (Activated) in the Treatment of Severe Sepsis

Drotrecogin alfa (activated): the treatment for severe sepsis?

Drotrecogin alfa: a new approach in the treatment of severe sepsis

EARLY- VERSUS LATE-ONSET SHOCK IN EUROPEAN INTENSIVE CARE UNITS